简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2020-03-16 17:22 OpenSesame Offers Free Access to Coronavirus Preparedness and Remote Work Training
2020-03-16 16:00 CGTN: Latest Data Shows Over 36,000 Patients Had Recovered in Wuhan
2020-03-16 10:35 Philip Morris International Demonstrates Commitment to Developing an Inclusive and Diverse Workplace with Appointment of Silke Muenster, Chief Diversity Officer
2020-03-16 10:33 Kirin’s View on Reports Issued by Proxy Advisory Firms
2020-03-13 14:07 Medical PDQ App is the Best Platform for COVID-19 Communication for Healthcare Providers and Patients
2020-03-13 13:52 Nearly 2 Million Airline Seats Affected by New Travel Ban, According to OAG Analysis
2020-03-13 10:11 U.S. FDA grants Fast Track designation to empagliflozin for the treatment of chronic kidney disease
2020-03-12 17:38 The Kidney Kid Superhero Initiative Goes International on World Kidney Day
2020-03-12 14:42 Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance
2020-03-12 14:14 RELIEF THERAPEUTICS Holding SA (SIX: RLF) announces the proposal of Prof. Jonathan Javitt, M.D., M.P.H., at the upcoming general assembly as Vice Chairman of the Board
2020-03-11 16:40 Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial
2020-03-11 15:57 Patient Safety Movement Foundation Appoints New Chairman; Announces Drive Toward Zero Preventable Patient Deaths By 2030
2020-03-10 18:05 Moody’s Offering Coronavirus Credit and Economic Research Free to the Public
2020-03-10 17:58 DIP Will Start Offering Relief Compensation to Those Who Are Employed in a Part-time or Contracted Capacity via DIP’s Services If They Are Unable to Work Due to a Coronavirus Related Illness
2020-03-06 18:31 AJ Vaccines To Develop Vaccine for COVID-19
2020-03-06 14:53 Terns Pharmaceuticals to Present Data from an Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH
2020-03-05 14:54 Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19
2020-03-04 18:19 H.E.L Group Focuses on Growth in China
2020-03-04 17:09 Takeda Receives Positive CHMP Opinion for ALUNBRIG® (brigatinib) as a First-Line Treatment for ALK+ Non-Small Cell Lung Cancer
2020-03-04 16:49 Takeda Completes Sale of Select OTC and Non-Core Assets to STADA

Business Wire Weibo

Press Releases

Latest Releases